Are Cataracts Hereditary? What to Know About Genetic Risk

Cataracts have a substantial hereditary component, but the genetic story depends on which type of cataract you’re talking about. Congenital cataracts, the kind present at birth or developing in early childhood, often follow clear-cut inheritance patterns traceable to single gene mutations. Age-related cataracts, the far more common variety that clouds vision later in life, are shaped by dozens of genes working alongside environmental factors like UV exposure, smoking, and diabetes. Twin studies estimate that roughly half the variation in age-related nuclear cataracts comes down to genetics, which makes heredity one of the strongest risk factors, even though it rarely gets the attention that lifestyle factors do.

Congenital Cataracts Follow Straightforward Inheritance

If a baby is born with a cataract or develops one in the first years of life, the cause is often a single gene mutation passed from parent to child. More than 100 genes have been linked to congenital cataract, and the most common inheritance pattern is autosomal dominant, meaning a child needs only one copy of the mutated gene (from one parent) to develop the condition.¹ Autosomal recessive and X-linked patterns exist too, but they’re less common.

The genes most often involved encode proteins that keep the lens transparent. Crystallins, which make up the bulk of lens protein, are the classic culprits. Connexins, which form channels between lens cells so they can share nutrients and signals, and various membrane and structural proteins round out the list.² When any of these proteins is misshapen because of a mutation, the orderly arrangement of the lens breaks down, light scatters instead of passing through cleanly, and the lens turns opaque.

One striking feature of congenital cataract genetics is the sheer variety. Even within a single family, the same mutation can produce cataracts that look quite different from one person to the next, varying in shape, density, and location within the lens. That variability makes clinical diagnosis tricky and is one reason genetic testing has become increasingly valuable for these patients.

Age-Related Cataracts Are About Half Genetic

Most people who develop cataracts do so in their 60s, 70s, or later, and those age-related cataracts have a more complex genetic picture. A landmark twin study published in the New England Journal of Medicine compared identical and fraternal twins and found that genetic factors explained about 48 percent of the variation in nuclear cataracts, the type that forms in the center of the lens. Age accounted for roughly 38 percent of the variation, and unique environmental exposures made up the remaining 14 percent.³

Cortical cataracts, the type that starts at the edges of the lens and works inward, appear to be even more heritable. A separate twin study estimated their heritability at 53 to 58 percent, depending on the grading method used.⁴ So if you have a close relative who developed cataracts, your own risk is meaningfully higher than average, though it’s far from a guarantee.

What’s notable about these numbers is that shared environment, growing up in the same household, eating similar diets, living in the same climate, did not significantly contribute to the twin study models. The environmental effects that mattered were unique to each individual. That suggests the environmental triggers for cataracts are things like personal UV exposure history, individual smoking habits, or metabolic conditions rather than broad household-level factors.

Genome-Wide Studies Are Mapping the Genetic Landscape

Unlike congenital cataracts, where a single gene mutation often does the job, age-related cataracts involve many genes each contributing a small amount of risk. Large-scale genome-wide association studies have been steadily cataloging these genetic variants. A major multiethnic analysis identified 54 locations in the genome significantly associated with cataract risk, 37 of which had never been flagged before.⁵ A more recent and larger meta-analysis pushed that number further, identifying 101 independent genome-wide significant locations, 57 of them novel.⁶

Some of the identified loci sit near genes expressed in eye tissue and involved in eye development. For instance, one analysis combining Asian and Caucasian populations found a particularly strong signal on chromosome 20, along with suggestive signals on chromosomes 8 and 3, all near genes known to be active in the eye.⁷ The newer meta-analysis also flagged several biological pathways and even identified four potential drug-gene interactions, which could eventually inform treatment.⁶

The practical takeaway is that there is no single “cataract gene” for age-related disease. Your genetic risk is the accumulated effect of many small-impact variants scattered across the genome. That’s why cataracts don’t follow a neat family pattern the way congenital cataracts often do. You might develop them at 65 while your sibling sails through to 85 with clear lenses, even though you share similar genetic backgrounds.

When Cataracts Are Part of a Bigger Genetic Condition

Some cataracts show up not as an isolated eye problem but as one feature of a broader inherited syndrome. Myotonic dystrophy is a well-known example. This condition, caused by an unstable expansion of repeated DNA sequences in the DMPK gene, primarily affects muscles but also reliably produces a distinctive pattern of “snowflake” cataracts.⁸ In fact, cataracts can be the first clue that someone has myotonic dystrophy. In one reported case, a mother was diagnosed with the condition after an eye exam, which then prompted testing of her teenage daughter, who also turned out to carry the mutation and had early cataracts despite no other complaints.⁸

Animal research has helped clarify why myotonic dystrophy causes cataracts. Mice lacking the Six5 gene, which sits near the repeat expansion on the same chromosome, develop cataracts, suggesting that reduced activity of this neighboring gene contributes to lens clouding in the disease.⁹ Myotonic dystrophy isn’t the only syndrome where cataracts appear. Down syndrome, galactosemia, and several rare metabolic disorders also carry increased cataract risk. For these patients, cataracts are a secondary consequence of the underlying genetic condition rather than a standalone problem.

Your Genes Shape How Vulnerable You Are to Environmental Damage

One of the more interesting findings in cataract genetics is that your DNA doesn’t just determine whether your lens proteins are normal. It also influences how well your eyes handle the environmental stresses that cause cataracts over time. UV radiation, for example, is a well-established cataract risk factor. It damages lens proteins through oxidative stress, creating the kind of protein clumping that makes the lens cloudy.¹⁰ But not everyone exposed to the same amount of sunlight develops cataracts at the same rate, and genetics appears to be part of the reason.

The glutathione-S-transferase (GST) enzyme family is a key player in protecting the lens from oxidative damage. People who carry deletion variants of certain GST genes, meaning they lack functional copies of those detoxification enzymes, appear to face higher cataract risk. One study found that individuals missing the GSTT1 gene, or missing both GSTM1 and GSTT1, had elevated risk of age-related cataracts.¹¹ A study of the Turkish population added a sex-specific wrinkle: women who lacked the GSTM1 gene had roughly three times the odds of developing cataracts compared to women who had functional copies, with the effect concentrated in the nuclear subtype.¹²

These findings matter because they illustrate how genetic risk and environmental exposure can multiply each other. A person with fully functional detoxification enzymes might tolerate years of UV exposure with relatively little lens damage, while someone carrying the deletion variants might be considerably more vulnerable to the same exposure. Wearing UV-blocking sunglasses is sensible advice for everyone, but it may be especially consequential for people whose genetics leave them with weaker antioxidant defenses.

Diabetes Adds a Genetic Layer to Cataract Risk

People with type 2 diabetes already face higher cataract risk because elevated blood sugar can directly damage lens proteins. But genetics can amplify this effect further. The aldose reductase gene, which encodes an enzyme involved in sugar metabolism within the lens, has been a focus of research for two decades. A study of Chinese patients with type 2 diabetes found that the occurrence of cataracts was correlated with age and with specific variants in the aldose reductase gene, with certain alleles appearing protective and others appearing harmful.¹³

What makes this especially interesting is the interaction between genotype and blood sugar control. A larger study found that carriers of a specific aldose reductase variant (the z-4 allele) who also had poor blood sugar control had about 43 percent higher odds of cataracts compared to non-carriers with good control. Carriers of the same variant whose blood sugar was well managed had no increased risk at all.¹⁴ A separate investigation confirmed this gene-environment interaction, finding that an aldose reductase variant was linked to cortical cataract only among people with elevated fasting blood glucose, not among those with normal levels.¹⁵

The practical message here is encouraging: even if you carry genetic variants that raise your cataract susceptibility in the context of diabetes, keeping blood sugar under good control seems to neutralize much of that added risk.

Ethnic and Population Differences in Cataract Prevalence

Cataract risk isn’t distributed evenly across populations, and some of that variation appears to be genetic rather than purely environmental. The Singapore Epidemiology of Eye Diseases Study, which compared three ethnic groups living in the same city and climate, found that Malay participants had significantly higher rates of nuclear, cortical, and posterior subcapsular cataracts than Chinese participants. The severity of all three cataract subtypes correlated with genetic ancestry in this Southeast Asian population, even after accounting for socioeconomic and lifestyle differences.¹⁶

Studies like this are valuable because they partially separate genetic from environmental contributions. When different ethnic groups share the same tropical climate, similar access to healthcare, and comparable socioeconomic conditions, yet still show different cataract rates, that difference points toward genetic factors. It also underscores why large genome-wide association studies need to include diverse populations rather than relying on data from a single ethnic group. Risk loci that matter in one population may not replicate in another, and vice versa.

Genetic Testing for Cataracts Today

For congenital cataracts, genetic testing has become genuinely useful. A study that sequenced 32 cataract-associated genes in 46 children with apparently nonsyndromic congenital cataracts found disease-causing mutations in 70 percent of cases. Over two-thirds of those mutations were previously unknown, and in almost two-thirds of cases, the test provided new information about the diagnosis or inheritance pattern that the family didn’t have before.¹⁷ That kind of result can help families understand recurrence risk for future children and can sometimes reveal an underlying syndromic condition that hadn’t been suspected.

For age-related cataracts, genetic testing is far less useful at the individual level. With 100-plus loci each contributing a tiny sliver of risk, no single test result is going to change your clinical management. A polygenic risk score that combines all known variants might eventually help identify people at highest risk early in life, but that remains a research tool, not something your eye doctor would order today. The most reliable predictors of age-related cataract risk remain simple: your age, whether you have diabetes, whether you smoke, your UV exposure history, and whether you’ve used corticosteroids long-term.

Research Into DNA Repair and Lens Aging

Recent lab work has been probing the molecular machinery that keeps lens cells healthy as they age. One line of research focuses on a DNA repair enzyme called APE1. When researchers engineered mice with a version of APE1 that couldn’t repair DNA properly, those mice developed significant lens clouding and cataracts. Their lens cells showed hallmarks of premature aging, including the accumulation of damage markers and the activation of cellular senescence pathways. The researchers traced part of the effect to the suppression of a downstream molecule called DHCR24. When they artificially restored DHCR24 levels, the premature aging of lens cells was partially reversed.¹⁸

Separately, work with mouse models carrying mutations in alpha-crystallin, one of the key lens proteins, has revealed that the lens’s ability to clean up misfolded proteins through a recycling process called autophagy is critical. When this cleanup system falters, damaged proteins pile up and the lens becomes opaque.¹⁹ These findings are far from the clinic, but they point toward possible future targets. If drugs could boost DNA repair or protein cleanup in the aging lens, it might slow or prevent cataract formation without surgery.

The Lanosterol Question and Nonsurgical Treatment Hopes

A few years ago, headlines proclaimed that eye drops containing lanosterol, a natural steroid-like molecule, could dissolve cataracts without surgery. The idea was that lanosterol might help reverse the protein clumping that makes the lens opaque. Understandably, the prospect excited a lot of people. Cataract surgery is safe and effective, but it’s still surgery, and a drop would be transformative for the hundreds of millions of people worldwide who lack access to operating rooms.

The genetic evidence, however, has been discouraging. A study that looked for associations between genetic variants influencing lanosterol levels and cataract risk found no statistically significant link. Neither the lanosterol synthase gene region nor a genetic risk score built from the cholesterol synthesis pathway showed any relationship with cataract outcomes.²⁰ That doesn’t definitively rule out a pharmacological effect at high concentrations delivered directly to the eye, but it does suggest that the natural biological variation in lanosterol levels within the body has no meaningful impact on whether you develop cataracts. The eye-drop cure remains unproven.

Meanwhile, CRISPR gene-editing technology is being explored for inherited eye diseases more broadly. Early work in mouse models has shown that CRISPR can correct mutations responsible for certain inherited retinal conditions, and researchers have begun investigating whether similar approaches could address inherited cataract mutations.²¹ This work is still in animal models and far from clinical use, but for families affected by severe congenital cataracts caused by known single-gene mutations, gene therapy represents a logical long-term prospect.

Steroid-Induced Cataracts and Individual Susceptibility

Long-term use of corticosteroids, whether oral, inhaled, or applied as eye drops, is a well-recognized cause of posterior subcapsular cataracts. But not everyone on steroids develops cataracts, and the speed at which they form varies enormously from person to person. This has long suggested an underlying genetic susceptibility, though pinpointing the responsible variants has proven difficult.

What is established at the molecular level is that synthetic steroids like dexamethasone activate the glucocorticoid receptor in lens cells, which then alters gene activity in ways that can damage the lens. Lab studies have confirmed that this effect works specifically through the glucocorticoid receptor rather than the closely related mineralocorticoid receptor, because blocking the glucocorticoid receptor stopped the effect while blocking the mineralocorticoid receptor did not.²² Individual differences in glucocorticoid receptor expression and in the downstream pathways it activates could plausibly explain why some people develop steroid cataracts quickly while others tolerate the same doses for years. Identifying the genetic variants responsible is an active area of research, but no clinically useful markers exist yet.

If you’re on long-term steroids for a condition like asthma, autoimmune disease, or after an organ transplant, regular eye exams are the main practical defense. There’s currently no genetic test that would tell your doctor whether you’re among those likely to develop steroid cataracts, so monitoring remains the standard approach regardless of your family history.